Skip to main content

Tweets

What early biomarkers are specific for SLE? How many will progress to stage 2? Who should we screen? Will patients revert to pre-stage 1? Is progression preventable? @DrDavidKarp on relevant questions we need to ask regarding preclinical stage 1 lupus. #RNL2024 @rheumnow https://t.co/bJPG68WdyE
TheDaoIndex @KDAO2011 ( View Tweet )
2 years 4 months ago
Can HCQ prevent SLE? Results of the MONA-LISA study is being analyzed (pts have +ANA and 1-2 SLICC criteria for SLE randomized to PCB or HCQ) - @DrDavidKarp @rheumnow #RNL2024 https://t.co/9yoFXS7wMe
TheDaoIndex @KDAO2011 ( View Tweet )
2 years 4 months ago
#RNL2024 @RheumNow @DrDavidKarp Incomplete lupus is heterogeneous term "Stage 2" pre-classification stage as ILE/UCTD Stage 1: non-specific antibodies, dysregulation 2: incomplete features 3: classified, multi-system disease 4: irreversible tissue damage https://t.co/CuLUzSZ24E
Eric Dein @ericdeinmd ( View Tweet )
2 years 4 months ago
@reumacia @RheumNow You are absolutely right. The point was not generally used for psoriasis ( not PsA). I was surprised my self 🤕. Here is the slide again by Dr. Armstrong , great talk by the way. Let me know if you want the handout. https://t.co/C11Gkn2jho
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
2 years 4 months ago
Appreciative inquiry in rheumatology and how to enhance and improve our clinical notes to frame our encounter in a positive manner. @BharatKumarMD #RNL2024 @RheumNow https://t.co/iTXwjUb6tg
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
2 years 4 months ago
Some takeways from JAK inhibitors in dermatology talk by Bruce Strober. Great talk. #RNL2024 @RheumNow https://t.co/fuRsSnnsha
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
2 years 4 months ago
Dermatology colleagues are using JAKis with success for wide range of dermatological diseases. Note the beauty of this slide with further elaboration on domain inhibition, cool stuff 🤓 Bruce Strober #RNL2024 @RheumNow https://t.co/2yHHcOgTC8
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
2 years 4 months ago
Allosteric versus active site inhibition by JAK. Never understood this better. Thanks to Bruce Strober. #RNL2024 @RheumNow https://t.co/r9hhHLO5oS
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
2 years 4 months ago
@BharatKumarMD at #RNL2024 @RheumNow Appreciative Inquiry in Rheumatology 5(ish) steps Dawn (what focus on) -> Discovery (what gives life) -> Dream (what might be) -> Design (what should be) -> Destiny (how can i execute) -> New Dawn - Empathy at center of inquiry https://t.co/gDhXpi94pT
Eric Dein @ericdeinmd ( View Tweet )
2 years 4 months ago
×